Valmet DNA: Execution with Unnecessary Privileges
CVE-2025-0416 is a high-severity execution with unnecessary privileges vulnerability in Valmet DNA from Valmet, with a CVSS 4.0 base score of 8.9 out of 10. It can be exploited from the same local network by an attacker with a low-privileged account, without any action from a user. Affected Valmet DNA versions: C2007 through C2022. The record does not name a fixed version, so check the vendor advisory. There is no confirmed exploitation so far. EPSS estimates a 0.21% chance of exploitation within 30 days, which is low compared with other CVEs.
High severity with no evidence of exploitation so far.
What to do
- Check which version of Valmet DNA you run against the affected versions below, and install the vendor's latest release.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| Valmet | Valmet DNA | C2007 through C2022 | Not stated |
Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- AdjacentThe attacker must be on the same local network segment.
- Attack complexity
- LowNo special conditions are needed; the attack works reliably.
- Attack requirements
- PresentThe target must be in a specific state or configuration for the attack to work.
- Privileges required
- LowA basic user account is enough.
- User interaction
- NoneNo action by a victim is required.
- Confidentiality (vulnerable system)
- HighSerious loss of confidentiality on the vulnerable system.
- Integrity (vulnerable system)
- HighSerious loss of integrity on the vulnerable system.
- Availability (vulnerable system)
- HighSerious loss of availability on the vulnerable system.
- Confidentiality (other systems)
- HighSerious loss of confidentiality on systems beyond the vulnerable one.
- Integrity (other systems)
- HighSerious loss of integrity on systems beyond the vulnerable one.
- Availability (other systems)
- HighSerious loss of availability on systems beyond the vulnerable one.
Vector: CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber. Scored by CNA.
Official description
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Execution with Unnecessary Privileges
The product performs an operation at a privilege level that is higher than the minimum level required, which creates new weaknesses or amplifies the consequences of other weaknesses.
How developers prevent this class of flaw
- Run your code using the lowest privileges that are required to accomplish the necessary tasks. If possible, create isolated accounts with limited privileges that are only used for a single task. That way, a successful attack will not immediately give the attacker access to the rest of the software or its environment. For example, database applications rarely need to run as the database administrator, especially in day-to-day operations.
- Identify the functionality that requires additional privileges, such as access to privileged operating system resources. Wrap and centralize this functionality if possible, and isolate the privileged code as much as possible from other code. Raise privileges as late as possible, and drop them as soon as possible to avoid CWE-271. Avoid weaknesses such as CWE-288 and CWE-420 by protecting all possible communication channels that could interact with the privileged code, such as a secondary socket that is only intended to be accessed by administrators.
- Identify the functionality that requires additional privileges, such as access to privileged operating system resources. Wrap and centralize this functionality if possible, and isolate the privileged code as much as possible from other code. Raise privileges as late as possible, and drop them as soon as possible to avoid CWE-271. Avoid weaknesses such as CWE-288 and CWE-420 by protecting all possible communication channels that could interact with the privileged code, such as a secondary socket that is only intended to be accessed by administrators.
More Execution with Unnecessary Privileges vulnerabilities (CWE-250)
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: none, automatable: no, technical impact: total).
- Record last changed materially (score, affected products, status or references).
References
Other references
Other vulnerabilities in Valmet DNA
- 7.0 High severity
Recent Execution with Unnecessary Privileges vulnerabilities
- 8.8 High severity
- 7.2 High severity
- 7.5 High severity
- 7.8 High severity
- 8.2 High severity
- 8.8 High severity
Spotted an error? Tell us.